Physical performance and Vitamin D in elderly black women-the PODA randomized clinical trial

John F. Aloia, Mageda Mikhail, Melissa Fazzari, Shahidul Islam, Louis Ragolia, Jack Guralnik

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Context: There is limited information on the influence of vitamin D on physical performance in black Americans. Objective: To determine if maintenance of serum 25(OH)D>75 nmol/L prevents a decline in physical performance. Design: The Physical Performance, Osteoporosis and Vitamin D in African American Women (PODA) trial had a prospective, randomized, placebo controlled, double-dummy design with two arms: one of which is placebo vitamin D3 adjusted to maintain serum 25(OH)D >75 nmol/L. Patients: The target population was healthy elderly black women with serum 25(OH)D between 20 and 65 nmol/L. The trial was 3 years in duration with measurement of physical performance every 6 months: grip strength, Short Physical Performance Battery (SPPB), 10 chair rises, and 6-minute walk distance. A total of 260 women entered the study and 184 completed 3 years. Mean age was 68.2 years. Baseline 25(OH)D was 53 nmol/L; total SPPB was 11 (10 to 12). Setting: Research center in an academic health center. Main Outcomes Measure: Prevention of decline in physical performance measures. Intervention: Participants were randomly assigned to placebo or active vitamin D. Vitamin D3 dose was adjusted to maintain serum 25(OH)D >75 nmol/L. Results: There was a decline with time in grip strength and the 6-minute walk test. The SPBB increased with time. There were no substantial differences between the placebo and active vitamin D3 groups with respect to the temporal patterns observed for any of the performance measures. Conclusion: There is no benefit of maintaining serum 25(OH)D>75 nmol/L in preventing the decline in physical performance in healthy black American women.

Original languageEnglish (US)
Pages (from-to)1441-1448
Number of pages8
JournalJournal of Clinical Endocrinology and Metabolism
Volume104
Issue number5
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Fingerprint

Cholecalciferol
Vitamin D
Randomized Controlled Trials
Placebos
Serum
Hand Strength
Health
Health Services Needs and Demand
African Americans
Osteoporosis
Maintenance
Outcome Assessment (Health Care)
Research

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Physical performance and Vitamin D in elderly black women-the PODA randomized clinical trial. / Aloia, John F.; Mikhail, Mageda; Fazzari, Melissa; Islam, Shahidul; Ragolia, Louis; Guralnik, Jack.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 104, No. 5, 01.01.2019, p. 1441-1448.

Research output: Contribution to journalArticle

Aloia, John F. ; Mikhail, Mageda ; Fazzari, Melissa ; Islam, Shahidul ; Ragolia, Louis ; Guralnik, Jack. / Physical performance and Vitamin D in elderly black women-the PODA randomized clinical trial. In: Journal of Clinical Endocrinology and Metabolism. 2019 ; Vol. 104, No. 5. pp. 1441-1448.
@article{ad8110250b184b179f87f397a39cb64c,
title = "Physical performance and Vitamin D in elderly black women-the PODA randomized clinical trial",
abstract = "Context: There is limited information on the influence of vitamin D on physical performance in black Americans. Objective: To determine if maintenance of serum 25(OH)D>75 nmol/L prevents a decline in physical performance. Design: The Physical Performance, Osteoporosis and Vitamin D in African American Women (PODA) trial had a prospective, randomized, placebo controlled, double-dummy design with two arms: one of which is placebo vitamin D3 adjusted to maintain serum 25(OH)D >75 nmol/L. Patients: The target population was healthy elderly black women with serum 25(OH)D between 20 and 65 nmol/L. The trial was 3 years in duration with measurement of physical performance every 6 months: grip strength, Short Physical Performance Battery (SPPB), 10 chair rises, and 6-minute walk distance. A total of 260 women entered the study and 184 completed 3 years. Mean age was 68.2 years. Baseline 25(OH)D was 53 nmol/L; total SPPB was 11 (10 to 12). Setting: Research center in an academic health center. Main Outcomes Measure: Prevention of decline in physical performance measures. Intervention: Participants were randomly assigned to placebo or active vitamin D. Vitamin D3 dose was adjusted to maintain serum 25(OH)D >75 nmol/L. Results: There was a decline with time in grip strength and the 6-minute walk test. The SPBB increased with time. There were no substantial differences between the placebo and active vitamin D3 groups with respect to the temporal patterns observed for any of the performance measures. Conclusion: There is no benefit of maintaining serum 25(OH)D>75 nmol/L in preventing the decline in physical performance in healthy black American women.",
author = "Aloia, {John F.} and Mageda Mikhail and Melissa Fazzari and Shahidul Islam and Louis Ragolia and Jack Guralnik",
year = "2019",
month = "1",
day = "1",
doi = "10.1210/jc.2018-01418",
language = "English (US)",
volume = "104",
pages = "1441--1448",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Physical performance and Vitamin D in elderly black women-the PODA randomized clinical trial

AU - Aloia, John F.

AU - Mikhail, Mageda

AU - Fazzari, Melissa

AU - Islam, Shahidul

AU - Ragolia, Louis

AU - Guralnik, Jack

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Context: There is limited information on the influence of vitamin D on physical performance in black Americans. Objective: To determine if maintenance of serum 25(OH)D>75 nmol/L prevents a decline in physical performance. Design: The Physical Performance, Osteoporosis and Vitamin D in African American Women (PODA) trial had a prospective, randomized, placebo controlled, double-dummy design with two arms: one of which is placebo vitamin D3 adjusted to maintain serum 25(OH)D >75 nmol/L. Patients: The target population was healthy elderly black women with serum 25(OH)D between 20 and 65 nmol/L. The trial was 3 years in duration with measurement of physical performance every 6 months: grip strength, Short Physical Performance Battery (SPPB), 10 chair rises, and 6-minute walk distance. A total of 260 women entered the study and 184 completed 3 years. Mean age was 68.2 years. Baseline 25(OH)D was 53 nmol/L; total SPPB was 11 (10 to 12). Setting: Research center in an academic health center. Main Outcomes Measure: Prevention of decline in physical performance measures. Intervention: Participants were randomly assigned to placebo or active vitamin D. Vitamin D3 dose was adjusted to maintain serum 25(OH)D >75 nmol/L. Results: There was a decline with time in grip strength and the 6-minute walk test. The SPBB increased with time. There were no substantial differences between the placebo and active vitamin D3 groups with respect to the temporal patterns observed for any of the performance measures. Conclusion: There is no benefit of maintaining serum 25(OH)D>75 nmol/L in preventing the decline in physical performance in healthy black American women.

AB - Context: There is limited information on the influence of vitamin D on physical performance in black Americans. Objective: To determine if maintenance of serum 25(OH)D>75 nmol/L prevents a decline in physical performance. Design: The Physical Performance, Osteoporosis and Vitamin D in African American Women (PODA) trial had a prospective, randomized, placebo controlled, double-dummy design with two arms: one of which is placebo vitamin D3 adjusted to maintain serum 25(OH)D >75 nmol/L. Patients: The target population was healthy elderly black women with serum 25(OH)D between 20 and 65 nmol/L. The trial was 3 years in duration with measurement of physical performance every 6 months: grip strength, Short Physical Performance Battery (SPPB), 10 chair rises, and 6-minute walk distance. A total of 260 women entered the study and 184 completed 3 years. Mean age was 68.2 years. Baseline 25(OH)D was 53 nmol/L; total SPPB was 11 (10 to 12). Setting: Research center in an academic health center. Main Outcomes Measure: Prevention of decline in physical performance measures. Intervention: Participants were randomly assigned to placebo or active vitamin D. Vitamin D3 dose was adjusted to maintain serum 25(OH)D >75 nmol/L. Results: There was a decline with time in grip strength and the 6-minute walk test. The SPBB increased with time. There were no substantial differences between the placebo and active vitamin D3 groups with respect to the temporal patterns observed for any of the performance measures. Conclusion: There is no benefit of maintaining serum 25(OH)D>75 nmol/L in preventing the decline in physical performance in healthy black American women.

UR - http://www.scopus.com/inward/record.url?scp=85063950478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063950478&partnerID=8YFLogxK

U2 - 10.1210/jc.2018-01418

DO - 10.1210/jc.2018-01418

M3 - Article

C2 - 30496578

AN - SCOPUS:85063950478

VL - 104

SP - 1441

EP - 1448

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 5

ER -